<mets:mets OBJID="eprint_96339" LABEL="Eprints Item" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mets="http://www.loc.gov/METS/"><mets:metsHdr CREATEDATE="2026-11-06T14:31:03Z"><mets:agent ROLE="CUSTODIAN" TYPE="ORGANIZATION"><mets:name>Arxiv Universal Publishings</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_96339_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>THE INTERPLAY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES MELLITUS: PATHOGENETIC MECHANISMS AND PREVENTIVE STRATEGIES</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Dilorom</mods:namePart><mods:namePart type="family">Urunbayeva</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Nigora</mods:namePart><mods:namePart type="family">Sadikova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Guliza</mods:namePart><mods:namePart type="family">Jo’rayeva</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>The interplay between non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM), and cardiovascular diseases (CVD) represents a pressing global health challenge due to their increasing prevalence and synergistic contribution to morbidity and mortality. NAFLD affects approximately 25-37% of the global population, with a significantly higher prevalence of 55-70% in individuals with T2DM, making it a critical comorbidity in this group. Both conditions are closely linked to metabolic syndrome, characterized by insulin resistance, dyslipidemia, and chronic low-grade inflammation, which collectively amplify the risk of CVD, the leading cause of death in T2DM patients. NAFLD is now recognized as an independent risk factor for CVD, with evidence suggesting that advanced liver fibrosis exacerbates cardiovascular outcomes. In regions like Uzbekistan, where obesity and T2DM rates are rising due to lifestyle changes and urbanization, the burden of NAFLD and its cardiovascular complications is becoming a public health priority. This research is highly relevant as it addresses the urgent need to understand the pathophysiological mechanisms linking these conditions and to develop integrated diagnostic and preventive strategies to reduce cardiometabolic morbidity. Furthermore, the study aims to contribute to global and regional efforts in improving early detection and management of NAFLD in T2DM patients, potentially reducing healthcare costs and improving quality of life.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-05-31</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_96339"><mets:rightsMD ID="rights_eprint_96339_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong>
In self-archiving this collection of files and associated bibliographic
metadata, I grant Arxiv Universal Publishings the right to store
them and to make them permanently available publicly for free on-line.
I declare that this material is my own intellectual property and I
understand that Arxiv Universal Publishings does not assume any
responsibility if there is any breach of copyright in distributing these
files or metadata. (All authors are urged to prominently assert their
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its
author:</strong> I hereby declare that the collection of files and
associated bibliographic metadata that I am archiving at
Arxiv Universal Publishings is in the public domain. If this is
not the case, I accept full responsibility for any breach of copyright
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the <em>Deposit Item Now</em> button indicates your agreement to these
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file SIZE="541194" MIMETYPE="application/pdf" ID="eprint_96339_17964_1" OWNERID="https://arxiv.universalpublishings.com/id/eprint/96339/1/286-289.pdf"><mets:FLocat xlink:href="https://arxiv.universalpublishings.com/id/eprint/96339/1/286-289.pdf" xlink:type="simple" LOCTYPE="URL"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div DMDID="DMD_eprint_96339_mods" ADMID="TMD_eprint_96339"><mets:fptr FILEID="eprint_96339_document_17964_1"></mets:fptr></mets:div></mets:structMap></mets:mets>